| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | YUN2306954 |
| InChI Key | KZSKGLFYQAYZCO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C28H22Cl3N3O5 |
| Molecular Weight | 586.86 |
| AlogP | 6.56 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 108.92 |
| Molecular species | ACID |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 39.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Bile acid receptor FXR agonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group H
Nuclear hormone receptor subfamily 1 group H member 4
|
15-41 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cholangitis, Sclerosing | 3 | D015209 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Liver Cirrhosis, Biliary | 2 | D008105 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1418274-28-8 |
| ChEMBL | CHEMBL4297613 |
| DrugBank | DB15168 |
| FDA SRS | YUN2306954 |
| Guide to Pharmacology | 10644 |
| PubChem | 71228883 |
| SureChEMBL | SCHEMBL14641986 |